New Developments in Breast Cancer
Dallas/Addison Marriott Quorum by the Galleria
Dallas, TX
September 20, 2008
| 7:30 am | Registration and Continental Breakfast |
| 8:00 am | Welcome, Introductions, and Presession Survey Stephen E. Jones |
| Advances in Chemotherapy and Endocrine Therapy | |
| 8:05 am | Local Control: Advances in Surgical and Radiation Strategies A. Marilyn Leitch |
| Case Discussion |
|
| 8:35 am | Molecular Diagnostics for Risk Assessment and Treatment Individualization William F. Symmans |
| Case Discussion |
|
| 9:05 am | Advances in Hormonal Therapies and Bone-Targeted Agents Cynthia Ma |
| Case Discussion |
|
| 9:35 am | Trends in Adjuvant and Neoadjuvant Chemotherapy for Early-Stage Breast Cancer Stephen E. Jones |
| Case Discussion |
|
| 10:05 am | Postsession Survey |
| 10:10 am | Panel Discussion |
| 10:20 am | Break |
| Novel Biologic and Chemotherapeutic Agents in Breast Cancer | |
| 10:35 am | Presession Survey |
| 10:40 am | Chemotherapeutic Options for Metastatic Breast Cancer Joanne Blum |
| Case Discussion |
|
| 11:10 am | Advances in HER2-Targeted Therapies for Early-Stage and Metastatic Breast Cancer Charles E. Geyer, Jr |
| Case Discussion |
|
| 11:40 am | Incorporating Angiogenesis Inhibitors Into Breast Cancer Treatment Strategies Angel Augusto Rodriguez |
| Case Discussion |
|
| 12:10 pm | Postsession Survey |
| 12:15 pm | Panel Discussion |
| 12:30 pm | Adjourn |
An educational grant for this activity was provided by: